We are live on ! Find out more
GRTS

Gritstone bio, Inc. Common Stock

Delisted

GRTS was delisted on the 21st of October, 2024.

79 hedge funds and large institutions have $86M invested in Gritstone bio, Inc. Common Stock in 2022 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 30 increasing their positions, 23 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

31% more call options, than puts

Call options by funds: $374K | Put options by funds: $285K

30% more repeat investments, than reductions

Existing positions increased: 30 | Existing positions reduced: 23

1% more capital invested

Capital invested by funds: $85.1M → $86M (+$870K)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

9% less funds holding

Funds holding: 8779 (-8)

53% less first-time investments, than exits

New positions opened: 7 | Existing positions closed: 15

Holders
79
Holders Change
-8
Holders Change %
-9.2%
% of All Funds
1.36%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
7
Increased
30
Reduced
23
Closed
15
Calls
$374K
Puts
$285K
Net Calls
+$89K
Net Calls Change
+$73K

GRTS Hedge Fund Activity: Q3 2022 in Review

79 of the 5,806 institutional investors tracked by Wall St. Rank reported a position in Gritstone bio, Inc. Common Stock (GRTS) for Q3 2022, worth a combined $86M — up 1% from $85.1M a quarter earlier.

Sellers outnumbered buyers: 15 funds closed out of GRTS and 7 opened new positions — a net loss of 8 holders — while 23 trimmed existing stakes and 30 added.

The largest buyer was Jacobs Levy Equity Management, adding an estimated $2.92M. The largest seller was Deep Track Capital, cutting an estimated $5.33M.

  • 79 institutional investors held Gritstone bio, Inc. Common Stock (GRTS) as of Q3 2022, down from 87 in Q2 2022.
  • Funds reported $86M of Gritstone bio, Inc. Common Stock stock for Q3 2022, up 1% quarter-over-quarter.
  • 7 funds opened new Gritstone bio, Inc. Common Stock positions in Q3 2022 and 15 closed out, a net change of -8 holders.
  • The largest Gritstone bio, Inc. Common Stock buyer in Q3 2022 was Jacobs Levy Equity Management, an estimated $2.92M added.
  • The largest Gritstone bio, Inc. Common Stock seller in Q3 2022 was Deep Track Capital, an estimated $5.33M sold.

Based on aggregated 13F filings for Q3 2022.